This open-label , multicenter , non-inferiority study enrolled antiretroviral experienced , HIV-infected adults currently receiving a regimen of TDF/FTC + ATV/r for 6 months with no history of virologic failure and whose HIV-1 RNA had been 75 copies/mL on 2 consecutive measurements including screening .